Frequency of positive anti hepatitis C virus antibodies among lichen planus patients
DOI:
https://doi.org/10.66344/jpad.32.2.2022.1930Abstract
Objective The purpose of this study was to determine frequency of positive Hepatitis C virus in lichen planus patients.  Methods It was a cross-sectional survey which was carried out from 06-08-2014 to 05-02-2015 at the Department of Dermatology, Jinnah Hospital, Lahore. Total 100 patients of lichen planus were enrolled. Antibody titre of Hepatitis C were measured by enzyme-linked immunosorbant assay of third generation.  Results Patients of age between 20-70 years were selected. Mean age was 40.55±14.38 years. Out of total 100 patients, 58 were male (58%) while remaining 42 were female (42.0%). Skin involvement was seen in 96 patients (96.0%), mucous membrane involvement in 21 patients (21.0%) and nails involvement in 8 patients (8.0%). Distribution of patients by type of lesions was as follows: nonerosive mucosal 13%, hypertrophic 80%, annular 1%, follicular 8%, nonerosive palmoplantar 5%, nail lesions 6%, atrophic 9%, erosive mucosal lesions 10%, guttate form 6%, actinic 8% and erosive palmoplantar lesions 1%. Hepatitis C antibody was positive in 23 patients (23.0%).  Conclusion  We discovered high frequency of positive HCV in lichen planus patients. We need a case-control study on a larger population to clarify our results.  Key words Lichen planus, hepatitis C virus, lichenoid eruption.Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.